Skip to content

Effects of Exercise on Metabolic Parameters in Patients With Type 2 Diabetes Mellitus

First Exercise Reports of Diabetes Centre: Effects of Exercise on Metabolic Parameters in Patients With Type 2 Diabetes Mellitus

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT04318184
Enrollment
88
Registered
2020-03-23
Start date
2018-01-02
Completion date
2019-12-10
Last updated
2020-03-23

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Diabetes Mellitus, Type 2

Keywords

Exercise, Type-2 Diabetes Mellitus treatment, Body Composition, Blood Samples, Blood Pressure

Brief summary

Diabetes is considered an epidemic disease with the 463 million affected patients (between 20-79 years) and it is estimated that 578 million people will have diabetes by 2030 \[1\]. According to The International Diabetes Federation (IDF) reports, 4,2 million adults were considered to die due to diabetes and its complications in 2019. Because of this situation, diabetes treatment is so important. The recommendations for the treatment of DM include medications and lifestyle management, which includes physical activity (PA), medical nutrition therapy, smoking cessation counseling, and psychosocial care. PA is an important aspect of management that directly under the control of the patients. So the investigators want to interrogate the effect of exercise on blood parameters, blood pressure, body compositions.

Detailed description

The data of the participants who came to the sports center where is prepared for the diabetes patients in the hospital will be collected from the past registration files on the electronic system. Sociodemographic data, blood values and bio-impedance measurements of each patient are collected coming to the sports center, routinely. Patients who had missing data, patients who did not complete the 3-month exercise program were excluded from the analysis. All analyses were performed using the Statistical Package for the Social Sciences (SPSS) version 22. 0 for Windows. Data are expressed as mean ± standard deviation. The one-sample Kolmogorov-Smirnov test was performed to assess the distribution of data. Due to their distribution, numerical variables in different subjects were compared with the t-test or Mann-Whitney U test. Comparison of variables before and after the exercise program were compared by the paired t-test (parametric variable) or Wilcoxon test (non-parametric variable). Probability values were two-tailed, and a p-value of less than 0.05 was considered as significant. All assessments were performed in the clinic at baseline and end of the 3rd month. The blood samples were collected. The systolic and diastolic blood pressure (SBP and DBP) were measured with an automatic arm BP monitor before and after every session. Body mass and body composition, including percent body fat, fat and fat-free mass, were determined using a bioelectric impedance system with the electrodes in contact with soles and heels of both feet. At the baseline and end of the third month, the same person repeated all assessments. Patients had recruited 3 sessions a week for 3 months (Monday/Wednesday/Friday). Every session consisted of aerobic exercise protocol and warm-up, cooldown period. Patients aerobic loading capacity was calculated before the every session using by Karvonen formula as submaximal loading.

Interventions

PROCEDUREAerobic exercise

The aerobic exercise protocol was performed 3 times a week for 3 months on the treadmill. Loading periods were performed according to the heart rate maximum using the Karvonen formula (%60-80 Heart rate maximum)

Sponsors

Marmara University
Lead SponsorOTHER

Study design

Allocation
NA
Intervention model
SINGLE_GROUP
Primary purpose
TREATMENT
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
18 Years to 65 Years
Healthy volunteers
No

Inclusion criteria

1. Persons who were diagnosed with DM, 2. Aged between 18 and 65 years, 3. Patients who completed the three-month exercise program.

Exclusion criteria

1. Had chronic drug (antidiabetic and antilipidemic) adjustments for 3 months at the beginning and during the exercise program, 2. Participated in an exercise program before, 3. Had a health condition other than DM associated with glucose metabolism.

Design outcomes

Primary

MeasureTime frameDescription
Change is being assessed for TriglycerideBaseline and end of the 3rd monthBlood parameters
Change is being assessed for LDLBaseline and end of the 3rd monthBlood parameters
Change is being assessed for HDLBaseline and end of the 3rd monthBlood parameters
Change is being assessed for Blood GlucoseBaseline and end of the 3rd monthBlood parameters
Change is being assessed for Post prandial glucoseBaseline and end of the 3rd monthBlood parameters
Change is being assessed for HbA1cBaseline and end of the 3rd monthBlood parameters
Change is being assessed Total CholesterolBaseline and end of the 3rd monthBlood parameters

Secondary

MeasureTime frameDescription
Change is being assessed for Muscle Mass (kg)Baseline and end of the 3rd monthEvaluation with bio-empedans device (TANITA)
Change is being assessed for BMIBaseline and end of the 3rd monthEvaluation with bio-empedans device (TANITA)
Change is being assessed for Blood PressureBaseline and end of the 3rd monthSistolic and Diastolic Pressure
Change is being assessed for Fat Mass (kg)Baseline and end of the 3rd monthEvaluation with bio-empedans device (TANITA)

Countries

Turkey (Türkiye)

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026